The vital signs monitoring devices market size has grown rapidly in recent years. It will grow from $11.07 billion in 2025 to $12.32 billion in 2026 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to increasing hospitalization rates, rising prevalence of chronic diseases, growing use of basic patient monitoring equipment, expansion of healthcare infrastructure, demand for routine vital sign assessment.
The vital signs monitoring devices market size is expected to see rapid growth in the next few years. It will grow to $18.68 billion in 2030 at a compound annual growth rate (CAGR) of 11%. The growth in the forecast period can be attributed to growth in home healthcare services, technological advancements in sensor technologies, rising geriatric population, increasing adoption of remote patient monitoring, demand for real-time clinical decision support. Major trends in the forecast period include growing adoption of continuous and remote vital signs monitoring, rising demand for portable and home healthcare monitoring devices, increased focus on early detection and preventive care, expansion of multi-parameter monitoring solutions, improved accuracy and reliability of non-invasive monitoring devices.
The rising incidence of cardiovascular diseases is expected to drive the expansion of the vital signs monitoring devices market in the coming years. Cardiovascular diseases encompass a range of disorders that impact the heart and blood vessels, frequently resulting in heart attacks, strokes, and other circulatory system issues. The prevalence of cardiovascular diseases is increasing due to higher rates of obesity, which raise the risk of hypertension, diabetes, and elevated cholesterol levels - factors that significantly contribute to heart-related problems. Vital signs monitoring devices play a crucial role in managing, diagnosing, and preventing cardiovascular diseases (CVDs). These devices aid in identifying early warning signs, tracking disease progression, and informing treatment strategies. For example, in October 2024, the US Centers for Disease Control and Prevention (CDC), a US government public health agency, reported that 919,032 individuals in the US died from cardiovascular disease in 2023, accounting for roughly one in every three deaths nationwide. Consequently, the growing prevalence of cardiovascular diseases is expected to propel the demand for vital signs monitoring devices.
Companies in the vital signs monitoring devices market are increasingly developing advanced technologies, such as early warning scoring tools integrated with monitoring devices, to minimize human error. These systems continuously monitor patient vital signs to detect early signs of clinical deterioration and prompt timely medical intervention. For instance, in July 2024, Huntleigh, a US-based medical equipment manufacturer, introduced the SC500 Series vital signs monitor. This high-performance device supports both spot checks and extended observations, bridging the gap between basic and multi-parameter monitors. It includes integrated early warning scoring tools and three-level alarms, making it ideal for long-term COVID-19 monitoring. The monitor features an 8-inch color display and can operate on battery or mains power. It provides comprehensive monitoring for adults, children, and newborns, including non-invasive blood pressure, pulse rate, pulse oximetry, 3-lead ECG, and an optional wireless tympanic temperature sensor. Additionally, the SC500 enhances workflow efficiency through standard connectivity options and compatibility with Smartsigns Central View monitoring software for centralized data management.
In September 2024, Becton, Dickinson and Company (BD), a US-based medical technology firm, acquired the Critical Care product group of Edwards Lifesciences Corporation for USD 4.2 billion. This acquisition allows Becton, Dickinson and Company to access advanced hemodynamic monitoring technologies, artificial intelligence (AI)-enabled clinical decision-support tools, and a portfolio of minimally invasive and noninvasive monitoring systems. As a result, the company enhances its smart connected care capabilities and strengthens its reach and integration across infusion and monitoring platforms. Edwards Lifesciences Corporation, based in the US, specializes in manufacturing advanced patient monitoring devices and sensors and is recognized for its leadership in hemodynamic monitoring technologies used in intensive care and surgical settings.
Major companies operating in the vital signs monitoring devices market are Medtronic Plc, Koninklijke Philips NV, GE Healthcare Technologies Inc, Omron Healthcare, Mindray Ltd, Masimo Corp, Nihon Kohden Corp, Lepu Medical Technology Co Ltd, Contec Medical Systems Co Ltd, A And D Company Ltd, Spacelabs Healthcare Inc, Schiller AG, Edan Instruments Inc, Shenzhen Comen Medical Instruments Co Ltd, Nonin Medical Inc, Recorders And Medicare Systems P Ltd, BPL Medical Technologies, SunTech Medical Inc, Rossmax International Ltd, Allengers Medical Systems Ltd, Huntleigh Healthcare LLC, BioBeat Technologies, Ababil Healthcare.
North America was the largest region in the vital signs monitoring devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vital signs monitoring devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vital signs monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the vital signs monitoring devices market by increasing costs of imported electronic components, sensors, and semiconductor-based parts used in monitoring systems. Portable and advanced monitoring device segments are most affected, particularly in Asia-Pacific regions such as China and Southeast Asia that serve as key manufacturing hubs. These cost pressures have led to higher device prices and supply chain adjustments. However, tariffs have also encouraged local manufacturing, component sourcing diversification, and investments in domestic production capabilities, supporting long-term market stability.
The vital signs monitoring devices market research report is one of a series of new reports that provides vital signs monitoring devices market statistics, including vital signs monitoring devices industry global market size, regional shares, competitors with a vital signs monitoring devices market share, detailed vital signs monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the vital signs monitoring devices industry. This vital signs monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Vital signs monitoring devices are essential medical instruments used to continuously or periodically measure and track key physiological parameters that indicate the body’s critical functions. These devices are integral to modern healthcare as they help monitor physiological patterns and assist healthcare professionals in making timely and informed clinical decisions.
The primary categories of vital signs monitoring devices include blood pressure monitors, pulse oximeters, temperature monitoring devices, and glucose monitors. Pulse oximeters are compact devices that assess the oxygen saturation level in a person's blood, typically by attaching to a finger or earlobe. These devices are available in both standalone and portable forms and are utilized across various settings such as hospitals, clinics, home care, ambulatory centers, emergency departments, and more.
The vital signs monitoring devices market consists of sales of respiratory rate monitors, wearable health trackers, multi-parameter patient monitors, and neonatal vital signs monitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The vital signs monitoring devices market size is expected to see rapid growth in the next few years. It will grow to $18.68 billion in 2030 at a compound annual growth rate (CAGR) of 11%. The growth in the forecast period can be attributed to growth in home healthcare services, technological advancements in sensor technologies, rising geriatric population, increasing adoption of remote patient monitoring, demand for real-time clinical decision support. Major trends in the forecast period include growing adoption of continuous and remote vital signs monitoring, rising demand for portable and home healthcare monitoring devices, increased focus on early detection and preventive care, expansion of multi-parameter monitoring solutions, improved accuracy and reliability of non-invasive monitoring devices.
The rising incidence of cardiovascular diseases is expected to drive the expansion of the vital signs monitoring devices market in the coming years. Cardiovascular diseases encompass a range of disorders that impact the heart and blood vessels, frequently resulting in heart attacks, strokes, and other circulatory system issues. The prevalence of cardiovascular diseases is increasing due to higher rates of obesity, which raise the risk of hypertension, diabetes, and elevated cholesterol levels - factors that significantly contribute to heart-related problems. Vital signs monitoring devices play a crucial role in managing, diagnosing, and preventing cardiovascular diseases (CVDs). These devices aid in identifying early warning signs, tracking disease progression, and informing treatment strategies. For example, in October 2024, the US Centers for Disease Control and Prevention (CDC), a US government public health agency, reported that 919,032 individuals in the US died from cardiovascular disease in 2023, accounting for roughly one in every three deaths nationwide. Consequently, the growing prevalence of cardiovascular diseases is expected to propel the demand for vital signs monitoring devices.
Companies in the vital signs monitoring devices market are increasingly developing advanced technologies, such as early warning scoring tools integrated with monitoring devices, to minimize human error. These systems continuously monitor patient vital signs to detect early signs of clinical deterioration and prompt timely medical intervention. For instance, in July 2024, Huntleigh, a US-based medical equipment manufacturer, introduced the SC500 Series vital signs monitor. This high-performance device supports both spot checks and extended observations, bridging the gap between basic and multi-parameter monitors. It includes integrated early warning scoring tools and three-level alarms, making it ideal for long-term COVID-19 monitoring. The monitor features an 8-inch color display and can operate on battery or mains power. It provides comprehensive monitoring for adults, children, and newborns, including non-invasive blood pressure, pulse rate, pulse oximetry, 3-lead ECG, and an optional wireless tympanic temperature sensor. Additionally, the SC500 enhances workflow efficiency through standard connectivity options and compatibility with Smartsigns Central View monitoring software for centralized data management.
In September 2024, Becton, Dickinson and Company (BD), a US-based medical technology firm, acquired the Critical Care product group of Edwards Lifesciences Corporation for USD 4.2 billion. This acquisition allows Becton, Dickinson and Company to access advanced hemodynamic monitoring technologies, artificial intelligence (AI)-enabled clinical decision-support tools, and a portfolio of minimally invasive and noninvasive monitoring systems. As a result, the company enhances its smart connected care capabilities and strengthens its reach and integration across infusion and monitoring platforms. Edwards Lifesciences Corporation, based in the US, specializes in manufacturing advanced patient monitoring devices and sensors and is recognized for its leadership in hemodynamic monitoring technologies used in intensive care and surgical settings.
Major companies operating in the vital signs monitoring devices market are Medtronic Plc, Koninklijke Philips NV, GE Healthcare Technologies Inc, Omron Healthcare, Mindray Ltd, Masimo Corp, Nihon Kohden Corp, Lepu Medical Technology Co Ltd, Contec Medical Systems Co Ltd, A And D Company Ltd, Spacelabs Healthcare Inc, Schiller AG, Edan Instruments Inc, Shenzhen Comen Medical Instruments Co Ltd, Nonin Medical Inc, Recorders And Medicare Systems P Ltd, BPL Medical Technologies, SunTech Medical Inc, Rossmax International Ltd, Allengers Medical Systems Ltd, Huntleigh Healthcare LLC, BioBeat Technologies, Ababil Healthcare.
North America was the largest region in the vital signs monitoring devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vital signs monitoring devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vital signs monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the vital signs monitoring devices market by increasing costs of imported electronic components, sensors, and semiconductor-based parts used in monitoring systems. Portable and advanced monitoring device segments are most affected, particularly in Asia-Pacific regions such as China and Southeast Asia that serve as key manufacturing hubs. These cost pressures have led to higher device prices and supply chain adjustments. However, tariffs have also encouraged local manufacturing, component sourcing diversification, and investments in domestic production capabilities, supporting long-term market stability.
The vital signs monitoring devices market research report is one of a series of new reports that provides vital signs monitoring devices market statistics, including vital signs monitoring devices industry global market size, regional shares, competitors with a vital signs monitoring devices market share, detailed vital signs monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the vital signs monitoring devices industry. This vital signs monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Vital signs monitoring devices are essential medical instruments used to continuously or periodically measure and track key physiological parameters that indicate the body’s critical functions. These devices are integral to modern healthcare as they help monitor physiological patterns and assist healthcare professionals in making timely and informed clinical decisions.
The primary categories of vital signs monitoring devices include blood pressure monitors, pulse oximeters, temperature monitoring devices, and glucose monitors. Pulse oximeters are compact devices that assess the oxygen saturation level in a person's blood, typically by attaching to a finger or earlobe. These devices are available in both standalone and portable forms and are utilized across various settings such as hospitals, clinics, home care, ambulatory centers, emergency departments, and more.
The vital signs monitoring devices market consists of sales of respiratory rate monitors, wearable health trackers, multi-parameter patient monitors, and neonatal vital signs monitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Vital Signs Monitoring Devices Market Characteristics
3. Vital Signs Monitoring Devices Market Supply Chain Analysis
4. Global Vital Signs Monitoring Devices Market Trends and Strategies
5. Vital Signs Monitoring Devices Market Analysis of End Use Industries
7. Global Vital Signs Monitoring Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Vital Signs Monitoring Devices Total Addressable Market (TAM) Analysis for the Market
9. Vital Signs Monitoring Devices Market Segmentation
10. Vital Signs Monitoring Devices Market Regional and Country Analysis
11. Asia-Pacific Vital Signs Monitoring Devices Market
12. China Vital Signs Monitoring Devices Market
13. India Vital Signs Monitoring Devices Market
14. Japan Vital Signs Monitoring Devices Market
15. Australia Vital Signs Monitoring Devices Market
16. Indonesia Vital Signs Monitoring Devices Market
17. South Korea Vital Signs Monitoring Devices Market
18. Taiwan Vital Signs Monitoring Devices Market
19. South East Asia Vital Signs Monitoring Devices Market
20. Western Europe Vital Signs Monitoring Devices Market
21. UK Vital Signs Monitoring Devices Market
22. Germany Vital Signs Monitoring Devices Market
23. France Vital Signs Monitoring Devices Market
24. Italy Vital Signs Monitoring Devices Market
25. Spain Vital Signs Monitoring Devices Market
26. Eastern Europe Vital Signs Monitoring Devices Market
27. Russia Vital Signs Monitoring Devices Market
28. North America Vital Signs Monitoring Devices Market
29. USA Vital Signs Monitoring Devices Market
30. Canada Vital Signs Monitoring Devices Market
31. South America Vital Signs Monitoring Devices Market
32. Brazil Vital Signs Monitoring Devices Market
33. Middle East Vital Signs Monitoring Devices Market
34. Africa Vital Signs Monitoring Devices Market
36. Vital Signs Monitoring Devices Market Competitive Landscape and Company Profiles
37. Vital Signs Monitoring Devices Market Other Major and Innovative Companies
40. Vital Signs Monitoring Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Vital Signs Monitoring Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses vital signs monitoring devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for vital signs monitoring devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vital signs monitoring devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Pulse Oximeters; Blood Pressure Monitors; Temperature Monitoring Devices; Glucose Monitoring Devices2) By Mount Type: Standalone; Portable
3) By End-Use: Hospitals; Physician’s Office; Home Healthcare; Ambulatory Centers; Emergency Care Centers; Other End-Uses
Subsegments:
1) By Pulse Oximeters: Fingertip Pulse Oximeters; Handheld Pulse Oximeters; Tabletop Or Benchtop Pulse Oximeters; Wrist-Worn Pulse Oximeters; Pediatric Pulse Oximeters2) By Blood Pressure Monitors: Automated Or Digital Blood Pressure Monitors; Manual Blood Pressure Monitors; Ambulatory Blood Pressure Monitors; Wrist Blood Pressure Monitors; Upper Arm Blood Pressure Monitors
3) By Temperature Monitoring Devices: Digital Thermometers; Infrared Thermometers; Non-Contact Clinical Thermometers; Wearable Continuous Temperature Monitoring Devices; Smart Thermometers
4) By Glucose Monitoring Devices: Self-Monitoring Blood Glucose (SMBG) Devices; Continuous Glucose Monitoring (CGM) Systems
Companies Mentioned: Medtronic Plc; Koninklijke Philips NV; GE Healthcare Technologies Inc; Omron Healthcare; Mindray Ltd; Masimo Corp; Nihon Kohden Corp; Lepu Medical Technology Co Ltd; Contec Medical Systems Co Ltd; A And D Company Ltd; Spacelabs Healthcare Inc; Schiller AG; Edan Instruments Inc; Shenzhen Comen Medical Instruments Co Ltd; Nonin Medical Inc; Recorders And Medicare Systems P Ltd; BPL Medical Technologies; SunTech Medical Inc; Rossmax International Ltd; Allengers Medical Systems Ltd; Huntleigh Healthcare LLC; BioBeat Technologies; Ababil Healthcare
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Vital Signs Monitoring Devices market report include:- Medtronic Plc
- Koninklijke Philips NV
- GE Healthcare Technologies Inc
- Omron Healthcare
- Mindray Ltd
- Masimo Corp
- Nihon Kohden Corp
- Lepu Medical Technology Co Ltd
- Contec Medical Systems Co Ltd
- A And D Company Ltd
- Spacelabs Healthcare Inc
- Schiller AG
- Edan Instruments Inc
- Shenzhen Comen Medical Instruments Co Ltd
- Nonin Medical Inc
- Recorders And Medicare Systems P Ltd
- BPL Medical Technologies
- SunTech Medical Inc
- Rossmax International Ltd
- Allengers Medical Systems Ltd
- Huntleigh Healthcare LLC
- BioBeat Technologies
- Ababil Healthcare
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 12.32 Billion |
| Forecasted Market Value ( USD | $ 18.68 Billion |
| Compound Annual Growth Rate | 11.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
